In 2006, the Federal Drug Administration approved a vaccine to help prevent certain types of the HPV virus that cause genital warts and/or cancer. Gardasil was marketed to young girls ages 11 and 12 and females ages 13 to 26. However recent studies show women are not the only ones at risk.
Rising HPV Concerns for Men and Boys
The CDC’s Advisory Committee on Immunization Practices recommend that boys ages 11 and 12 receive the HPV vaccine, Gardasil. 7,500 cancer diagnoses caused by HPV were detected in men each year including anal cancer, throat cancer, and penile cancer.
Although HPV can cause cervical cancer for women and a number of cancers in men, genital warts are extremely common in the United States. Gential warts are caused by HPV types 6 and 11 and can also be prevented with the series of Gardasil shots.
According to the Society of Obstetricians and Gynecologists of Canada’s’ CEO , extending vaccination programs to boys could both protect them against genital warts and cancers caused by the HPV viruses and should cut the risk of girls becoming infected through sexual contact.
Where is the Gardasil Vaccine Approved for Men and Boys?
Gardasil is approved for use in men ages 22-26 as well, although it is a permissive recommendation which differs from females.
The CDC reports, that about 1% of sexually active men in the U.S. have genital warts at one time.
Gay and bisexual men and men with weaker immune systems are all recommended by health experts to receive the vaccine through the age of 26.
By approving vaccination for men and boys, contracting the HPV virus may be at a lower risk for the future.
Vaccines Near You
For more information about the HPV virus and vaccine eligibility call your local doctor, clinic, or visit www.cdc.gov.
GET HELP NOW!
You Only Have Three Years To File Your Claim
The first step in helping yourself or a loved one after a serious vaccine related injury is to contact us for a free review of your case.